NCT00304278 Study of RADPLAT and Tarceva in Locally Advanced Head and Neck Squamous Cell Carcinoma (SCCA) Status COMPLETED Phase PHASE2
NCT00301028 Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00293579 Pemetrexed Chemotherapy in Poor-Risk Patients With Advanced Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00293462 GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer Status COMPLETED Phase PHASE3
NCT00291707 Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT00291434 Altered and Conventional Fractionated Radiotherapy in Patients With Head and Neck Cancer Status COMPLETED Phase N/A
NCT00281866 Erlotinib in Treating Patients With Metastatic and/or Recurrent Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00281840 Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00280891 Review of Palliative Radiotherapy in the Management of Advanced Head and Neck Cancer Status COMPLETED Phase N/A
NCT00276523 PEG-interferon Alfa-2b in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer That Can Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00272181 Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer Status TERMINATED Phase PHASE2
NCT00270790 EVALUATION OF AMIFOSTINE FOR MUCOSAL AND HEMOPOETIC PROTECTION AND CARBOPLATIN, TAXOL, RADIOTHERAPY IN THE MANAGEMENT OF PATIENTS WITH HEAD AND NECK CANCER.(GCC 0202) Status COMPLETED Phase PHASE2
NCT00268372 S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx Status TERMINATED Phase PHASE3
NCT00265941 Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer Status COMPLETED Phase PHASE3
NCT00258310 Ph II Long Term/Low Dose Xeloda in Head and Neck Squamous Cell Carcinoma After Surgery, Radiation & or Chemo Status COMPLETED Phase PHASE2
NCT00256308 Adjuvant Chemoradiation With Weekly Oxaliplatin in Resected Head and Neck Cancer Status TERMINATED Phase PHASE2
NCT00248560 Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00245349 Study to Calculate the Radiation Dosimetry in Subjects With Head and Neck Cancer Status COMPLETED Phase N/A